Keros Therapeutics, Inc. (KROS)
11.36
+0.13
(+1.16%)
USD |
NASDAQ |
May 27, 16:00
11.36
0.00 (0.00%)
After-Hours: 16:47
Keros Therapeutics Cash from Investing (Quarterly) : -0.073M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Sarepta Therapeutics, Inc. | -134.39M |
| PTC Therapeutics, Inc. | -93.74M |
| Insmed, Inc. | 265.52M |
| United Therapeutics Corp. | 743.70M |
| Enanta Pharmaceuticals, Inc. | 11.94M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -3.529M |
| Cash from Financing (Quarterly) | -2.316M |
| Free Cash Flow | -58.25M |
| Free Cash Flow Per Share (Quarterly) | -0.1835 |
| Free Cash Flow to Equity (Quarterly) | -3.03M |
| Free Cash Flow to Firm (Quarterly) | -3.602M |
| Free Cash Flow Yield | -16.02% |